Cardiac Ablation Market

Cardiac Ablation Market by Technology (Radiofrequency, Electrical, Cryoablation, Ultrasound, Microwave), Product (Irreversible Electroporation, HIFU, MRgFUS), Application (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery) - Global Forecast to 2019

Report Code: UC 1644 Dec, 2018, by marketsandmarkets.com

The global cardiac ablation market is poised to grow at a CAGR of 12.5% during 2014-2019, and is expected to reach a value of ~$883.1 Million in 2019. A number of factors such as growing geriatric population coupled with increasing population base of cardiovascular disease patients, technological advancements in the field of ablation devices, and growing awareness about benefits of cardiac ablation procedures over conventional therapeutic and surgical procedures are fuelling the growth of the global cardiac ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.

The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of cardiac ablation products. A number of factors such as success of microwave ablation procedure in clinical trials to treat atrial fibrillation, growing adoption of ablation in CVS disease treatment, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the players’ active in the Cardiac ablation market.

Advanced Cardiac Therapeutics (U.S.), Alcon Laboratories Inc. (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Biosense Webster Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), Medtronic Plc (U.S.), Olympus Corporation (Japan), and St Jude Medical, Inc. (U.S.) are some of the key players in this market.

Scope of the Report

This research report categorizes cardiac ablation market into the following segments and sub-segments:

Cardiac Ablation Market, by Technology

  • Radiofrequency (RF) Ablation
  • Electrical Ablation
  • Cryoablation
  • Ultrasound Ablation
  • Microwave Ablation

Cardiac Ablation Market, by Product

  • Radiofrequency (RF) Ablators
    • Temperature-controlled Radiofrequency Ablators
    • Fluid-cooled Radiofrequency Ablators
    • Robotic Catheter Manipulation Systems
  • Electrical Ablators
    • Argon Plasma/Beam Coagulators
    • Irreversible Electroporation Systems
  • Cryoablation Devices
    • Tissue Contact Probes
    • Tissue Spray Probes
  • Ultrasound Ablators
    • High-intensity Focused Ultrasound Ablators
    • Magnetic Resonance Guided Focused Ultrasound Ablators
    • Ultrasound Ablation Systems
  • Microwave Ablators
    • Microwave Thermotherapy Devices

Cardiac Ablation Market, by Application

  • Cardiac Rhythm Management
    • Cardiac Arrhythmia
    • Atrial Fibrillation and Flutter
    • Tachycardia
  • Open Surgery
  • Others

Cardiac Ablation Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Factor Analysis
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
           2.2.3 Supply-Side Analysis
    2.3 Market Size Estimation
           2.3.1 Top-Down Approach
           2.3.2 Bottom-Up Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 History, Evolution, and Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Product
           5.2.3 Market, By Application
    5.3 Market Evolution
    5.4 Market Dynamics
           5.4.1 Key Market Drivers
           5.4.2 Key Market Restraints
           5.4.3 Key Market Opportunities
           5.4.4 Key Market Challenges

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Cardiac Ablation Market, By Technology
    7.1 Introduction
    7.2 Radiofrequency (RF) Ablation
    7.3 Electrical Ablation
    7.4 Cryoablation
    7.5 Ultrasound Ablation
    7.6 Microwave Ablation

8 Cardiac Ablation Market, By Product
    8.1 Introduction
    8.2 Radiofrequency (RF) Ablators
           8.2.1 Temperature-Controlled Radiofrequency Ablators
           8.2.2 Fluid-Cooled Radiofrequency Ablators
           8.2.3 Robotic Catheter Manipulation Systems
    8.3 Electrical Ablators
           8.3.1 Argon Plasma/Beam Coagulators
           8.3.2 Irreversible Electroporation Ablators
    8.4 Cryoablation Devices
           8.4.1 Tissue Contact Probes
           8.4.2 Tissue Spray Probes
    8.5 Ultrasound Ablators
           8.5.1 High-Intensity Focused Ultrasound Ablators
           8.5.2 Magnetic Resonance Guided Focused Ultrasound Ablators
           8.5.3 Ultrasound Ablation Systems
    8.6 Microwave Ablators
           8.6.1 Microwave Thermotherapy Devices

9 Cardiac Ablation Market, By Application
    9.1 Introduction
    9.2 Cardiac Rhythm Management
           9.2.1 Cardiac Arrythmia
           9.2.2 Atrial Fibrillation and Flutter
           9.2.3 Tachycardia
    9.3 Open Surgery
    9.4 Others

10 Cardiac Ablation Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (Row)

11 Competitive Landscape
     11.1 Introduction
     11.2 Market Share Analysis, By Key Players
     11.3 Competitive Scenario
     11.4 Recent Developments
             11.4.1 New Products Launches and Product Enhancements
             11.4.2 Agreements, Partnerships, and Agreements
             11.4.3 Mergers and Acquisitions
             11.4.4 Geographic Expansions
             11.4.5 Other Developments

12 Compny Profiles*
     12.1 Introduction
     12.2 Advanced Cardiac Therapeutics 
             12.2.1 Business Overview**
             12.2.2 Financial Overview
             12.2.3 Product Portfolio
             12.2.4 Key Strategies
             12.2.5 Recent Developments
     12.3 Alcon Laboratories Inc.
     12.4 Angiodynamics, Inc. 
     12.5 Atricure, Inc. 
     12.6 Biosense Webster (A Subsidiary of Johnson & Johnson Inc.)
     12.7 Boston Scientific Corporation
     12.8 Conmed Corporation
     12.9 Medtronic, PLC
     12.10 Olympus Corporation
     12.11 St. Jude Medical, Inc.

13 Appendix
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1644
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Ablation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved